Acute Cholecystitis
Persistent cystic-duct obstruction inflames the gallbladder rather than causing transient biliary colic: assess for sepsis and common-bile-duct disease, give supportive and antimicrobial treatment when indicated, and arrange early source control.
In a nutshell
Acute cholecystitis is persistent gallbladder inflammation, usually from cystic-duct obstruction. Combine clinical assessment with LFTs and ultrasound, investigate jaundice or cholestasis for common-bile-duct stones, give supportive and antimicrobial treatment when indicated, and offer laparoscopic cholecystectomy within 1 week. Drainage is for selected patients in whom surgery is unsafe or unavailable.
Classic presentation
Constant right-upper-quadrant pain with fever or systemic inflammation, RUQ tenderness or a positive Murphy sign, and ultrasound evidence of gallstones or gallbladder inflammation.
Key points
- Unlike biliary colic, acute cholecystitis is persistent inflammation: pain is constant and systemic inflammatory features are common.
- NICE recommends liver-function tests and ultrasound for suspected gallstone disease; ultrasound is the first-line imaging test.
- Jaundice, abnormal liver tests or a dilated bile duct should trigger MRCP, and EUS if MRCP is non-diagnostic, to assess for common-bile-duct stones.
- Treat sepsis and give antibiotics when clinically indicated, using local antimicrobial policy and current BNF for agent, dose, renal adjustment and duration; antibiotics do not replace source control.
- Offer early laparoscopic cholecystectomy within 1 week of diagnosis. Do not default to weeks of conservative treatment and delayed surgery.
- If common-bile-duct stones are present, clear the duct surgically or with ERCP before or at cholecystectomy; a biliary stent is temporary if ERCP cannot clear the duct.
- For empyema when surgery is contraindicated and conservative treatment fails, offer percutaneous cholecystostomy and reconsider surgery when fit. Specialist EUS-guided drainage is an option when surgery is not possible.
- Peritonism, shock, organ dysfunction, emphysematous disease or failure to improve requires urgent senior surgical and critical-care escalation.
First-line investigation
Liver-function tests and transabdominal ultrasound, followed by MRCP or EUS if the bile duct is dilated or liver tests are abnormal despite no duct stone on ultrasound.
Management
Stabilise and assess severity
Confirm gallbladder disease and check the duct
- Perform LFTs and ultrasound. If the bile duct is dilated or LFTs are abnormal without a detected duct stone, arrange MRCP and consider EUS if MRCP is non-diagnostic.1
Treat infection and obtain source control
Drain or clear the biliary system selectively
Exam traps
- A positive Murphy sign and inflammatory markers support cholecystitis but do not exclude cholangitis, pancreatitis, perforation or another acute abdomen.
- Jaundice or a markedly cholestatic liver-test pattern is not typical isolated cholecystitis; investigate the common bile duct.
- Do not use a normal or equivocal ultrasound to overrule a deteriorating septic patient; escalate and consider alternative or complicated disease.
- Antibiotics are supportive treatment, not definitive source control when the patient is fit for cholecystectomy.
- Percutaneous cholecystostomy is not routine first-line treatment; NICE reserves it for empyema when surgery is contraindicated and conservative management has failed.
- If early surgery within one week is not achievable, follow the NICE pathway and senior surgical decision-making rather than inventing an interval plan.
- Gallstone pancreatitis and acute cholangitis have separate pathways; do not force every biliary presentation into acute cholecystitis.
Illustrations
Key sources
- NICE CG188: Gallstone disease: diagnosis and management (CG188, current recommendations supported by 2018 surveillance)Published 29 Oct 2014 | Updated 31 Aug 2018
- NICE HTG617: Percutaneous insertion of a cystic duct stent after cholecystostomy for acute calculous cholecystitis (Current treatments and procedure, published 9 March 2022)Published 9 Mar 2022
- NICE HTG683: Endoscopic ultrasound-guided gallbladder drainage for acute cholecystitis when surgery is not an option (Recommendations, published 22 June 2023)Published 22 Jun 2023
- NICE NG253: Suspected sepsis in people aged 16 or over: recognition, assessment and early management (Current sepsis recognition and management recommendations)Published 19 Nov 2025 | Updated 5 Dec 2025
- BNF: Paracetamol (BNF analgesic monograph)
- BNF: Morphine sulfate (BNF opioid analgesic monograph)
- BNF: Co-amoxiclav (BNF antimicrobial monograph)
- BNF: Metronidazole (BNF antimicrobial monograph)
- BNF: Ceftriaxone (BNF antimicrobial monograph)
- NICE QS104: Gallstone disease, quality statement 1 (Adults with acute cholecystitis have laparoscopic cholecystectomy within 1 week of diagnosis)Published 3 Dec 2015
This page is exam revision material, not medical advice, and must not be used for patient care. Always check drug doses against the BNF and current guidance. Full disclaimer.

